DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Abacavir Sulfate And Lamivudine is a drug marketed by Aurobindo Pharma Ltd, Cipla, Lupin Ltd, Teva Pharms Usa, and Zydus Pharms. and is included in six NDAs.
The generic ingredient in ABACAVIR SULFATE AND LAMIVUDINE is abacavir sulfate; lamivudine. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the abacavir sulfate; lamivudine profile page.
A generic version of ABACAVIR SULFATE AND LAMIVUDINE was approved as abacavir sulfate; lamivudine by TEVA PHARMS USA on September 29th, 2016.
Recent Clinical Trials for ABACAVIR SULFATE AND LAMIVUDINE
Identify potential brand extensions & 505(b)(2) entrants
|ViiV Healthcare||Phase 4|
|Gilead Sciences||Phase 3|